CLB Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Core Laboratories Inc (CLB) is not a strong buy at the moment for a beginner investor with a long-term strategy. The company's recent downward revision in earnings guidance, coupled with a lack of significant positive catalysts, suggests a cautious approach. While the technical indicators are neutral to slightly positive, the lack of strong growth signals and negative sentiment from recent news make it prudent to hold off on buying.
The MACD histogram is positive and expanding (0.0812), indicating slight bullish momentum. RSI is neutral at 54.788, and moving averages are converging, suggesting no clear trend. The stock is trading near its pivot level of 16.152, with resistance at 16.827 and support at 15.478.
Gross margin increased significantly in Q4 2025, up 20.95% YoY, indicating operational efficiency improvements.
No recent insider or hedge fund activity indicates a lack of confidence.
In Q4 2025, revenue grew by 6.98% YoY to $138.26 million. However, net income dropped by 4.34% YoY to $7.08 million, and EPS fell by 6.25% YoY to $0.15. Gross margin improved to 18.13%, up 20.95% YoY.
No recent updates on analyst ratings or price target changes. Wall Street sentiment appears neutral.
